Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 7Phase NA 4Phase EARLY_PHASE1 3Phase 3 3Phase 1/2 3

Status

Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Lymphoid 1

Conditions

Breast Neoplasms 13Neoplasms 12Glioma 12Prostatic Neoplasms 11Glioblastoma 11Colorectal Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Melanoma 8Lymphoma, B-Cell 8Lymphoma 8Recurrence 7Multiple Myeloma 7Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Lung Neoplasms 3Carcinoma, Transitional Cell 3

Interventions

fludarabine 2Cyclophosphamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × 90 days × Clear all
NCT07586709 2026-05-14

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Chinese PLA General Hospital

Phase EARLY_PHASE1 Not yet recruiting
18 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT07519187 2026-04-09

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

The General Hospital of Western Theater Command

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Affiliated Hospital to Academy of Military Medical Sciences

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡